NASA, Partners Announce LAUNCH: Systems Challenge Forum

NASA, the U.S. Agency for International Development (USAID), the U.S. State Department and Nike Inc. will host the fifth forum of the LAUNCH initiative at NASA's Jet Propulsion Laboratory in Pasadena, Calif. Friday, Sept. 27 and Saturday, Sept. 28.

This year's forum, LAUNCH: Systems Challenge, seeks to identify and accelerate solutions in futuristic materials that will help enable exploration beyond our atmosphere and reduce humanity's harmful footprint on our planet. Ten finalists were chosen to attend the forum to work with experts from government and industry.

During the forum, LAUNCH innovators will discuss their most pressing business and program issues with LAUNCH Council members, who represent the business, textile, investment, international development, policy, engineering, science, communications and sustainability sectors. The sessions are designed to identify key challenges and opportunities for the entrepreneurs' innovations in an effort to accelerate their solutions toward greater global impact.

Innovators were chosen for their groundbreaking technologies and programs. Considerations included the potential to revolutionize the future of fabrics and low-impact production; demonstration of a clear commitment to positive social and environmental impact and reducing the harmful consumption of planetary resources; and the potential to help unlock a new era of exploration.

A link to live video of the conference, along with additional information on the innovations, is available online at:

Welcome

Media interested in attending the forum should contact Molly Conroy at Molly.Conroy@nike.com.

For more information about NASA and agency programs, visit:

Home Page

Please follow SpaceRef on Twitter and Like us on Facebook.

Go here to read the rest:

NASA, Partners Announce LAUNCH: Systems Challenge Forum

NASA Picks 10 Innovative Space Tech Ideas for Funding

NASA has awarded grants 10 innovative university projects that promise to help the space agency develop the advanced technologies it needs for future long-duration manned spaceflights and research.

The agency's Space Technology Research Grants Program will give about $250,000 to each of the one-year projects, with the possibility of another year of funding contingent on technical progress, NASA officials announced Wednesday (Sept. 25).

Some projects are aimed at developing the space technologies NASA needs for lengthy manned space missions beyond low-Earth orbit, including proposals to improve the recovery ofoxygen from carbon dioxide for astronaut life-support systems, and enhancing the storage and transfer of cryogenic fuel in a zero gravity environment. [NASA's Space Tech Goals for 2014 (Gallery)]

Other projects will explore advanced optics technologies that could help scientists obtain better measurements of distant cosmic objects, which could lead to a better understanding of exoplanets, galaxy evolution and the early moments of the universe, NASA officials said in a statement.

Still other projects will explore new ways to trackasteroidsthat could pose a threat to humanity.

These early stage innovation grants are given out under NASA's relatively newSpace Technology Program, which was born out of President Barack Obama's fiscal year 2011 budget request. The program is intended to spur innovative ideas from commercial industries, universities and even citizens.

"A critical element of America's space technology pipeline rests in the cutting edge research in the early stage technologies conducted at the nation's universities," NASA's Associate Administrator for Space Technology, Michael Gazarik, said in a statement. "Through this investment NASA will continue to benefit from university-led R and D."

Below is a list of the universities and proposal titles that NASA selected:

Follow us@Spacedotcom,FacebookandGoogle+. Original article onSPACE.com.

Read the original here:

NASA Picks 10 Innovative Space Tech Ideas for Funding

NASA Selects Early Stage Innovation Proposals from 10 Universities

NASA has selected 10 university-led proposals for study of innovative, early stage space technologies that address high priority technical needs America's space program must master to enable future missions.

The one-year grants from NASA's Space Technology Research Grants Program are worth about $250,000 each, with an additional year of research possible. Selected proposals address technology challenges that may improve astrophysics scientific instruments, oxygen recovery for space life support systems, cryogenic propellant storage for long-duration space exploration, our identification, characterization and protection from near-Earth asteroids.

"A critical element of America's space technology pipeline rests in the cutting edge research in the early stage technologies conducted at the nation's universities," said NASA's Associate Administrator for Space Technology, Michael Gazarik, in Washington. "Through this investment NASA will continue to benefit from university-led R and D."

The selected technology research areas require dramatic improvements over existing capabilities for future science and human exploration missions. Early stage, or low technology readiness level, technologies could mature into tools that solve the difficult challenges facing future NASA missions.

Universities selected for NASA's early stage innovation grants and the titles of their proposals are:

- Johns Hopkins University, Baltimore; "Detection, tracking, and identification of asteroids through on-board image analysis" - Michigan Technological University, Houghton, Mich.; "A new experiment for determining evaporation and condensation coefficients of cryogenic propellants and development of an efficient computational model of cryogenic film stability in microgravity" - Northwestern University, Evanston, Ill.; "Broadband electrically tunable monolithic mid-infrared laser" - Purdue University, West Lafayette, Ind.; "Innovations in understanding and modeling cryogenic propellants for long-duration spaceflight" - University of Arkansas, Fayetteville; "Asynchronous A/D converter for in situ instruments operating under extreme environments" - University of Colorado, Boulder; "Comprehensive modeling of the effects of hazardous asteroid mitigation techniques" - University of Florida, Gainesville; "Bio-inspired broadband antireflection coatings at long wavelengths for space applications" - University of Michigan, Ann Arbor; "Broad bandwidth metamaterial antireflection coatings for measurement of the cosmic microwave background" - University of South Carolina, Columbia; "Oxygen recovery via carbon dioxide electrolysis with microtubular solid oxide cells" - University of Utah, Salt Lake City; "A lightweight compact multi-spectral imager using novel computer-generated micro-optics and spectral-extraction algorithms"

The selected efforts will explore new science instrument technologies to better understand the history, climates, evidence of past life and future potential habitability of planets and moons within our solar system.

Researchers will investigate advances in optics technologies. These could enable the challenging science measurements that may contribute to the understanding of the first moments of the universe, the characterization of galaxy evolution over time and the characterization of newly found exoplanets, which are planets outside our solar system.

Researchers also will explore technologies that are needed for future long duration human space exploration beyond low-Earth orbit, including improvements in the recovery of oxygen from carbon dioxide, as well as greatly increasing the capability to store and transfer cryogenic fluids in a zero gravity environment.

In addition, researchers will develop technologies to better understand and protect our planet from near-Earth asteroids. Advancing early stage technologies will help with characterizing, understanding, and planning how to mitigate the threat of near-Earth asteroids.

Original post:

NASA Selects Early Stage Innovation Proposals from 10 Universities

NASA radar device detects heartbeats in disaster rubble

NASA is collaborating with the US Department of Homeland Security on a portable radar device that can detect heartbeats and breathing after a disaster.

The Finder unit during a test.

When a disaster strikes, there's a very short window of time in which to locate and free survivors trapped under rubble. The Finder portable radar system, developed through a collaboration between NASA and the US Department of Homeland Security, could make it much easier for emergency responders to find victims.

"Finder" is short for "Finding Individuals for Disaster and Emergency Response." The device works by sending a low-power microwave radar signal through the rubble. The signals that bounce back are analyzed for patterns that indicate a person's breathing or heartbeat.

The technology is related to radar systems NASA uses to locate spacecraft on their missions. "Detecting small motions from the victim's heartbeat and breathing from a distance uses the same kind of signal processing as detecting the small changes in motion of spacecraft like Cassini as it orbits Saturn," says James Lux, the Finder task manager at NASA's Jet Propulsion Lab.

The heavy lifting for this technology is done on the data processing side. It takes advanced algorithms to differentiate between a human's chest moving versus a rat scurrying, or a plant's leaves waving.

Finder can see through up to 20 feet of solid concrete. The device has been in testing for about a year. The whole unit weighs less than 20 pounds and could be useful for a variety of disaster scenarios, from tornadoes to earthquakes.

Locating disaster victims is Finder's first purpose, but NASA is looking ahead at potential uses in space. The system could be adapted to monitor astronauts without the need for wires. Meanwhile, on Earth, the technology could be ready and available for wider use by spring of 2014.

Read more:

NASA radar device detects heartbeats in disaster rubble

NASA Media Resources Available on New International Climate Report

NASA will make scientists and data visualizations available to journalists Friday, Sept. 27, with the release of a portion of the Fifth Assessment Report from the United Nations' Intergovernmental Panel on Climate Change (IPCC).

The IPCC will issue the "Summary for Policymakers" of the "Physical Science Basis of Climate Change" section of the report in Stockholm on Friday and the full text of that section Monday, Sept. 30. Additional sections will be released in the coming months.

More than 25 NASA scientists helped author and review the Fifth Assessment Report. NASA also will provide unique data visualizations of projected temperature and precipitation changes for the 21st century, based on climate models referenced in the report.

NASA satellite observations, scientific analysis and climate modeling contributed to the report's conclusions on such topics as temperature change, sea level rise, changes to glaciers and ice sheets, and Earth's global energy balance. NASA climate models contributed to the international modeling effort to project climate change throughout the 21st century. NASA scientists also played a key role in evaluating climate model accuracy by comparing models to NASA satellite observations.

The following NASA scientists -- listed with their hosting NASA facilities and points of contacts for media interviews -- participated in the "Physical Science Basis of Climate Change" and the "Summary for Policymakers":

Goddard Institute for Space Studies, New York: Drew Shindell, coordinating lead author, Chapter 8: Anthropogenic and Natural Radiative Forcing; drafting author, Summary for Policymakers Gavin Schmidt, expert reviewer, Chapters: 1: Introduction; 5: Information from Paleoclimate Archives; 8: Anthropogenic and Natural Radiative Forcing, and; 9: Evaluation of Climate Models Media contact: Leslie McCarthy at leslie.m.mccarthy@nasa.gov or 212-678-5507.

Goddard Space Flight Center, Greenbelt, Md.: Joey Comiso, coordinating lead author, Chapter 4: Observations: Cryosphere Peter Hildebrand, expert reviewer, Chapter 4: Observations: Cryosphere Media contact: Rani Gran at rani.c.gran@nasa.gov or 301-286-2483.

Jet Propulsion Laboratory, Pasadena, Calif.: Graeme Stephens, contributing author, Chapter 7: Clouds and Aerosols; lead author, Chapter 8: Anthropogenic and Natural Radiative Forcing; expert reviewer, Chapter 9: Evaluation of Climate Models Eric Rignot (JPL/University of California-Irvine), lead author, Chapter 4: Observations: Cryosphere Duane Waliser, expert reviewer, Chapter 9: Evaluation of Climate Models Media contact: Alan Buis at alan.d.buis@jpl.nasa.gov or 818-354-0474.

The visualizations of climate model projections show how global temperature and precipitation patterns are expected to change through the year 2100. The projections are based on the carbon emissions scenarios used in "Physical Science Basis of Climate Change." The visualizations will be available online at 8 a.m. EDT Sept. 27 at: http://go.nasa.gov/18rLWnq

For more information about NASA programs, visit: http://www.nasa.gov/

Visit link:

NASA Media Resources Available on New International Climate Report

Your plastic grocery bags can now be recycled into Nanotechnology

By: News Desk

That grocery-store plastic bag you just threw away might be the future of nanotechnology. Scientists at the University of Adelaide have developed a way to turn plastic bags into carbon nanotube membranes. These membranes are sophisticated and costly, with the potential to be used for energy storage and biomedical innovations.

Plastic bags represent a huge threat to the environment. They aren't biodegradable, Americans use over 100 billion (yes, that's billion with a b) of them, and only 1% are recycled. Thousands of marine animals and birds die of plastic pollution. And the environmental benefits to this "upcycling" (a play on recycling that means converting a waste product into something more valuable) these plastic bags could be important, at least according to Professor Dusan Losic, who led the team. "Transforming these waste materials through 'nanotechnological recycling' provides a potential solution for minimizing environmental pollution at the same time as producing high-added value products."

Similar research has been done before, Vilas Ganpat Pol at the Argonne National Laboratory converted plastic bags into nanotubes suitable for use in lithium-ion batteries. But Professor Dusan Losic's method has broader applications, and uses a new method. Here's the science: Dusan vaporized the plastic bags in a high-heat furnace, providing nanoporous alumina membranes with carbon pores that allowed the carbon nanotubes to grow.

The process is extremely complex, but shows that carbon-based "non-degradable wastematerial [such] as commercial plastic bags can be directly used to produce such sophisticated nanodevices as CNTs membranes." And in layman's terms, that could be a very good thing.

H/T Marc Sollinger

See the rest here:

Your plastic grocery bags can now be recycled into Nanotechnology

Galax-C – ”Medicine Cabinet” (Prod. Chris Calor) *NEW* *SEPTEMBER* 720p – Video


Galax-C - #39; #39;Medicine Cabinet #39; #39; (Prod. Chris Calor) *NEW* *SEPTEMBER* 720p
What was going to be the Intro for the highly anticipated mixtape One 800 comes out sometime in October for futher notice make sure to follow us on Twitter,I...

By: Guich Boyz

Go here to read the rest:

Galax-C - ''Medicine Cabinet'' (Prod. Chris Calor) *NEW* *SEPTEMBER* 720p - Video

Daniel Bryan WINS – The Shield Gets a Taste of Their Own Medicine – YES! – Reaction by JDV – Video


Daniel Bryan WINS - The Shield Gets a Taste of Their Own Medicine - YES! - Reaction by JDV
YES! Daniel Bryan wins, pinning Seth Rollins and defeating The Shield in a huge tag match with the many WWE Superstars supporting Daniel Bryan in a tag match...

By: Conservative New Media

See original here:

Daniel Bryan WINS - The Shield Gets a Taste of Their Own Medicine - YES! - Reaction by JDV - Video

Nuclear Medicine Market & Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation …

NEW YORK, Sept. 26, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Nuclear Medicine Market & Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecast to 2017 http://www.reportlinker.com/p01650887/Nuclear-Medicine-Market--Radiopharmaceuticals-%5BSPECT/PET-Radioisotopes-Technetium-F-18%5D-%5BBeta/Alpha-radiation-therapy-I131-Y-90%5D-%5BApplications-Cancer/Oncology-Cardiac%5D--Stable-Isotopes-Deuterium-C-13---Global-Trends--Forecast-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

Nuclear Medicine Market & Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecast to 2017

The global radiopharmaceuticals market was valued at $3.8 billion in 2012 and is poised to reach $5.5 billion by 2017 at a CAGR of 7.8%.

A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as Europe, North America, Japan, the Republic of Korea, and Oceania between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 and OSIRIS in France in 2018 is, however, a major threat for manufacturers.

The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects, radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy.

North America is the dominant market for diagnostic radioisotopes with 49% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Covidien, Plc (Ireland), GE Healthcare (U.K.), IBA Group (Belgium), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Siemens Healthcare (PETNET) (Germany).

The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) (U.S.) and Isotec (Sigma Aldrich) (U.S.) - in 2012; they jointly contributed more than 90% to the global revenue.

Scope of the Report

The radioisotope and stable isotope markets have been segmented according to the type of isotope, and applications. Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

View original post here:

Nuclear Medicine Market & Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation ...

Penn Medicine's Garret FitzGerald Named Ohio State Heart Program 2013 Schottenstein Laureate

Newswise PHILADELPHIA - Garret FitzGerald, MD, FRS, professor of Medicine and Pharmacology; chair of the Department of Pharmacology; and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine, University of Pennsylvania is the 2013 recipient of the Jay and Jeanine Schottenstein Prize in Cardiovascular Sciences from The Ohio State University Wexner Medical Centers Heart and Vascular Center.

The Schottenstein Prize, established with a $2 million gift from philanthropists Jay and Jeanie Schottenstein, is awarded to an international leader in the clinical sciences of cardiovascular medicine, cardiothoracic surgery, or the basic sciences of molecular or cellular cardiology. With the gift, the Schottenstein Laureate receives an honorarium of at least $100,000. FitzGerald will receive the award, one of the largest in the field, during a ceremony in Columbus on Oct 2.

I am honored to receive this prize, which reflects on the dedication and hard work of so many people with whom Ive been privileged to work and collaborate, says FitzGerald.

His research takes an integrative approach to elucidating the mechanisms of drug action, drawing on work in cells, model organisms, and humans. His work contributed substantially to the development of low-dose aspirin for cardioprotection. His team discovered how lower doses of aspirin than had been previously used to treat pain and inflammation act on blood cells called platelets to shut down their role in blocking arteries to cause heart attacks and strokes. Low-dose aspirin is now used for this purpose throughout the world and has saved the lives of tens of millions of people. His group was also the first to predict and then mechanistically explain the cardiovascular hazard from nonsteroidal antinflammatory drugs - NSAIDs. Between his work on aspirin and NSAIDs, he has benefited ten, if not hundreds, of millions of patients worldwide. His laboratory also described the first molecular clock in the cardiovascular system.

While in Columbus, FitzGerald will lecture during a special Grand Rounds in the Richard M. Ross Heart Hospital and meet with cardiovascular researchers at the Dorothy M. Davis Heart and Lung Research Institute.

For more information view the Ohio State release.

### Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.

Go here to read the rest:

Penn Medicine's Garret FitzGerald Named Ohio State Heart Program 2013 Schottenstein Laureate

Penn Medicine Radiation Oncology Chair Named Among 2013 ASTRO Fellows

ATLANTA Stephen M. Hahn, MD, chairman of the Department of Radiation Oncology and Henry K. Pancost Professor of Radiation Oncology in the Perelman School of Medicine and Abramson Cancer Center at the University of Pennsylvania, has been named among the ten 2013 Fellows of the American Society for Radiation Oncology.

Dr. Hahn became the chair of Penn Medicines Department of Radiation Oncology in 2005, after joining Penns faculty in 1996. During his tenure, he has overseen the opening of the Roberts Proton Therapy Center, the worlds largest and most advanced center integrating both proton beam radiation therapy and conventional radiation.

He received the FASTRO recognition this week during the organizations 55th Annual Meeting at the Georgia World Congress Center in Atlanta.

Awarded annually since 2006, ASTROs Fellows Program honors radiation oncology leaders who have been an ASTRO member for at least 15 years and have made substantial contributions to the field of radiation oncology in the areas of research, education, patient care or service, and leadership. Including the 2013 class of 10 Fellows, 212 of ASTROs more than 10,000 members worldwide have received the FASTRO designation.

Prior to his arrival at Penn, Dr. Hahn served as chief of the National Cancer Institutes Prostate Cancer Clinic, Clinical Pharmacology Branch, in Bethesda, MD, and as senior investigator at the NCI. He also served as a Commander in the NCIs U.S. Public Health Service from 1989 to 1995.

Dr. Hahns research and clinical care concentrates on cancers of the lung and genitourinary system, as well as radiation biology and photodynamic therapy. He is board certified in Internal Medicine, Radiation Oncology, and Hematology/Oncology, and is a graduate of the Temple University School of Medicine and Rice University. He completed his internal medicine residency atthe University of California, San Francisco and received fellowship training in both medical oncology and radiation oncology at the NCI. He has been a longtime member and leader of various ASTRO committees and initiatives.

These 10 new Fellows join an elite group of ASTRO members who have significantly impacted ASTRO, the specialty and cancer patients worldwide through their leadership in and service to research, education and patient care efforts, said ASTRO President Colleen A. F. Lawton, MD, FASTRO. Congratulations to my esteemed colleagues on receiving the ASTRO Fellow designation.

To read more about the 2013 FASTRO awardees, visit the ASTRO web site.

View post:

Penn Medicine Radiation Oncology Chair Named Among 2013 ASTRO Fellows